Prescription Alternatives Tacrolimus Suspension 0.02% Ophthalmic (3 products)

Recall announced November 15, 2018 by Prescription Alternatives, Inc, posted by the U.S. Food and Drug Administration (FDA). Reason: Lack of sterility assurance. The agency has closed this recall.

Where sold
Dispensed to K9 patients.
Last updated
November 19, 2026

Products included

Read the official notice. Always compare the codes on your package with the official notice. It is the final word.

Has your pet used this product and seems unwell? Call your veterinarian or an emergency animal hospital now.

See all pet recalls